- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Elicio Therapeutics Inc (ELTX)
Elicio Therapeutics Inc stock price live, this page displays NASDAQ ELTX stock exchange data. View the ELTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Elicio Therapeutics Inc real time stock price chart below.
What Is the Elicio Therapeutics Inc Stock Price Today?
The Elicio Therapeutics Inc stock price today is 10.55.
What Is the Stock Symbol for Elicio Therapeutics Inc?
The stock symbol for Elicio Therapeutics Inc is "ELTX."
What Stock Exchange Does Elicio Therapeutics Inc Trade On?
Elicio Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Elicio Therapeutics Inc a Good Stock to Buy?
Determining whether Elicio Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELTX quote. (ISIN: US28657F1030)
What Is the Elicio Therapeutics Inc Stock Price Today?
The Elicio Therapeutics Inc stock price today is 10.55.
What Is the Stock Symbol for Elicio Therapeutics Inc?
The stock symbol for Elicio Therapeutics Inc is "ELTX."
What Stock Exchange Does Elicio Therapeutics Inc Trade On?
Elicio Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Elicio Therapeutics Inc a Good Stock to Buy?
Determining whether Elicio Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ELTX quote. (ISIN: US28657F1030)
10.55
-0.23(-2.09%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.41
11.22
52 wk Range
4.85
14.93
ELTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.4111.22
52 wk Range
4.8514.93
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ELTX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
17.50
Upside
+65.88%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form S-3/A Elicio Therapeutics Inc For: 13 March
- Investing.com
- Form 424B5 Elicio Therapeutics Inc For: 16 March
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.50
(+65.88% Upside)
Earnings
Latest Release
Mar 12, 2026
EPS / Forecast
-0.50 / -0.69
Revenue / Forecast
-- / --
Compare ELTX to Peers and Sector
Metrics to compare | ELTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipELTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.9x | −4.2x | −0.5x | |
PEG Ratio | −0.13 | −0.04 | 0.00 | |
Price/Book | 118.7x | 6.4x | 2.6x | |
Price / LTM Sales | - | 9.2x | 3.3x | |
Upside (Analyst Target) | 62.5% | 192.3% | 47.1% | |
Fair Value Upside | Unlock | −11.2% | 6.2% | Unlock |
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Elicio Therapeutics (ELTX) Stock Price Today?
The Elicio Therapeutics stock price today is 10.55 USD.
What Stock Exchange Does Elicio Therapeutics Trade On?
Elicio Therapeutics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Elicio Therapeutics?
The stock symbol for Elicio Therapeutics is "ELTX."
What Is the Elicio Therapeutics Market Cap?
As of today, Elicio Therapeutics market cap is 198.13M USD.
What Is Elicio Therapeutics's Earnings Per Share (TTM)?
The Elicio Therapeutics EPS (TTM) is -2.58.
From a Technical Analysis Perspective, Is ELTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Elicio Therapeutics Stock Split?
Elicio Therapeutics has split 0 times.
How Many Employees Does Elicio Therapeutics Have?
Elicio Therapeutics has 33 employees.
What is the current trading status of Elicio Therapeutics (ELTX)?
As of May 05, 2026, Elicio Therapeutics (ELTX) is trading at a price of 10.55 USD, with a previous close of 10.77 USD. The stock has fluctuated within a day range of 10.41 USD to 11.22 USD, while its 52-week range spans from 4.85 USD to 14.93 USD.
What Is Elicio Therapeutics (ELTX) Price Target According to Analysts?
The average 12-month price target for Elicio Therapeutics is 17.50 USD, with a high estimate of 18 USD and a low estimate of 17 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +65.88% Upside potential.
What Is the ELTX After Hours Price?
ELTX's last after hours stock price is 11.19 USD, the stock has decreased by 0.42, or 3.90%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.